SCHEMBL6091382

SCHEMBL6091382

Cc1cccc(COc2cccc(OCCOc3ccccc3)c2)c1OCC#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CDK4 P11802 1/20 0.40
CCNB1 P14635 1/20 0.40
CCND1 P24385 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
NR4A2 P43354 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
MAOB P27338 3/20 0.38
LMNA P02545 2/20 0.37
MAPK1 P28482 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.37
DRD2 P14416 2/20 0.36
DRD4 P21917 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090892 0.90 BCHE (0.40) NR4A2MAOB
SCHEMBL6089139 0.88 SMN1; SMN2 (0.36) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6089097 0.85 FFAR1 (0.45) NR4A2SMN1; SMN2MAOB
SCHEMBL5725097 0.85 CHRNB2 (0.40) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL5725263 0.84 SCN8A (0.38) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6088282 0.84 ALOX5 (0.42) RAB9A
SCHEMBL6089925 0.83 ABCB1 (0.42) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6088303 0.82 NOS3 (0.46) SMN1; SMN2MAOBMAPK1KMT2AHTT
SCHEMBL6088875 0.82 MAOB (0.53) NPC1RAB9AMAOBDRD2KMT2A
SCHEMBL6088358 0.81 BCHE (0.38) CCNB2CDK1CDK4CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed